Journal Information
Vol. 213. Issue 8.
Pages 388-393 (November 2013)
Share
Share
Download PDF
More article options
Visits
296
Vol. 213. Issue 8.
Pages 388-393 (November 2013)
Clinical up-date
Resistant hypertension
Hipertensión arterial resistente
Visits
296
P. Armarioa,
Corresponding author
parmario@csi.cat

Corresponding author.
, A. Oliverasb, A. de la Sierrac
a Unidad de HTA y Riesgo Vascular, Área de Enfermedades Cardiovasculares, Hospital Moisés Broggi (Sant Joan Despi/Hospitalet), Universidad de Barcelona, Spain
b Unidad de Hipertensión Arterial, Servicio de Nefrología, Hospital Universitario del Mar, Universidad Autónoma de Barcelona, Spain
c Servicio de Medicina Interna, Hospital Mutua Terrassa, Universidad de Barcelona, Terrassa, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (4)
Table 1. Causes of secondary arterial hypertension that frequently appear as resistant hypertension.
Table 2. Main drugs and substances that can increase blood pressure.
Table 3. Use of spironolactone in the treatment of resistant AHT.
Table 4. Studies conducted with renal sympathetic denervation for managing resistant hypertension.
Show moreShow less
Abstract

A 53-year-old woman with hypercholesterolemia treated with statins, with no history of cardiovascular disease, was referred to the Hypertension and Vascular Risk Unit for management of hypertension resistant to 4 antihypertensive agents at full doses. The patient had obesity, with a body mass index of 36.3kg/m2 and office BP 162/102mmHg. Physical examination showed no data of interest. Analysis: glucose 120mg/dL, glycated Hb: 6.4%, albuminuria 68mg/g, kidney function and study of the renin angiotensin system and other biochemical parameters were normal. Echocardiography: left ventricular mass, 131g/m2 (normal, <110g/m2). True resistant hypertension was confirmed by ambulatory monitoring of blood pressure during 24h. Spironolactone treatment (25mg/day) was added and was well tolerated, with no change in renal function and kaliemia within normal (4.1mmol/l) following the treatment. After 8 weeks, blood pressure was well controlled: Office blood pressure 132/86mmHg and 24h-ambulatory BP: 132/86mmHg and PA-24: 128/79mmHg.

Keywords:
Hypertension
Ambulatory monitoring of blood pressure
Hypercholesterolemia
Resumen

Mujer de 53 años de edad, con antecedentes patológicos de hipercolesterolemia tratada con estatinas, sin antecedentes de enfermedades cardiovasculares, remitida a la Unidad de hipertensión arterial (HTA) y Riesgo Vascular por presentar HTA resistente a 4 fármacos antihipertensivos a dosis plenas. En la exploración física destacaba obesidad (IMC) 36,3kg/m2 y presión arterial (PA) clínica de 162/102mmHg. La exploración física no mostró datos de interés. Analítica: glucemia 120mg/dL, Hb glicada 6,4%. Albuminuria 68mg/g creatinina, con función renal, estudio del eje renina angiotensina y resto de analítica dentro de la normalidad. Ecocardiogarma: masa de ventrículo izquierdo, 131g/m2 (normal, <110g/m2). La HTA resistente se confirmó mediante monitorización ambulatoria de la presión arterial (MAPA) durante 24horas (153/89mmHg). Se añadió al tratamiento espironolactona 25mg/día, que fue bien tolerado, sin cambios en la función renal y con caliemia tras el tratamiento dentro de la normalidad (4,1mmol/L). A los 8 semanas presentaba un buen control de PA clínica, 132/86mmHg y de la PA-24h, 128/78mmHg.

Palabras clave:
Hipertensión arterial
Monitorización ambulatoria de la presión arterial
Hipercolesterolemia

Article

These are the options to access the full texts of the publication Revista Clínica Española (English Edition)
Member
Si es usted socio de FESEMI siga los siguientes pasos:

Diríjase desde aquí a la web de la >>>FESEMI<<< e inicie sesión mediante el formulario que se encuentra en la barra superior, pulsando sobre el candado.

Una vez autentificado, en la misma web de FESEMI, en el menú superior, elija la opción deseada.

>>>FESEMI<<<

Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Clínica Española (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Idiomas
Revista Clínica Española (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?